Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety

Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVATM) A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors